RxDoctor Payments Data

Kunal Dalal

Gastroenterology · Camden, NJNPI 1518341023

Payments from drug & device makers

$1,996in general payments, 2019–2025

Across 106 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$296
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$286
  • AbbVie$249
  • Johnson & Johnson$187
  • Conmed Corporation$175
  • Lilly USA, LLC$108
  • plus $694 from 18 others

What the payments were for

  • Food & beverage$1,996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,996 in reported general payments places this provider in the 45th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey

Medicare billing

Part B allowed, 2024
$70,631
Medicare patients
276
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase17$38,944
LinzessLinaclotide60$35,692
CreonLipase/Protease/Amylase19$30,319
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg115$2,705
Pantoprazole Sodium321$2,686
Famotidine274$2,657
PrevaliteCholestyramine11$2,629
Cholestyramine LightCholestyramine11$1,607
Omeprazole134$1,497
Ursodiol16$1,382
Sucralfate24$815
Esomeprazole Magnesium35$684
Dicyclomine Hcl29$492
Amitriptyline Hcl24$283
Doxycycline Hyclate13$154

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$249$66,01179 claims
Aimmune Therapeutics, Inc.Zenpep$17$38,94417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 701 gastroenterology providers in New Jersey.

Other gastroenterology in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →